Medlern Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 05-11-2024
- Paid Up Capital ₹ 0.17 M
as on 05-11-2024
- Company Age 4 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -15.20%
(FY 2023)
- Profit 88.08%
(FY 2023)
- Ebitda 88.13%
(FY 2023)
- Net Worth 81.82%
(FY 2023)
- Total Assets -57.20%
(FY 2023)
About Medlern
The Corporate was formerly known as Impelsys Healthcare Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.17 M, as per Ministry of Corporate Affairs (MCA) records.
Sameer Shariff, Mubeena Shariff, and Alf Dybdahl serve as directors at the Company.
- CIN/LLPIN
U85100KA2020PTC133846
- Company No.
133846
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Apr 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Medlern?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sameer Shariff  | Director | 20-Apr-2020 | Current |
| Mubeena Shariff | Director | 20-Apr-2020 | Current |
Alf Dybdahl  | Director | 23-Feb-2024 | Current |
Financial Performance and Corporate Structure Insights of Medlern.
Medlern Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.2% decrease. The company also saw a substantial improvement in profitability, with a 88.08% increase in profit. The company's net worth Soared by an impressive increase of 81.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medlern?
In 2023, Medlern had a promoter holding of 66.67% and a public holding of 33.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Impelsys Private LimitedActive 24 years 26 daysSameer Shariff and Mubeena Shariff are mutual person
- Mubeena Shariff Chocolatier Private LimitedActive 13 years 10 months
Sameer Shariff and Mubeena Shariff are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medlern?
Unlock and access historical data on people associated with Medlern, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medlern, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medlern's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
